Sphingosine 1-phosphate as a link between blood coagulation and inflammation

Cellular Physiology and Biochemistry

Volumn 34, Issue 1, 2014, Pages 185-196

  Rauch, Bernhard Hermann ^a  

^a UNIVERSITY MEDICINE GREIFSWALD   (Germany)

Author keywords

Atherosclerosis; Factor Xa; Monocyte; Platelet; Sphingosin 1 phosphate; Sphingosine kinase; Thrombin; Vascular smooth muscle

Indexed keywords

ACETYLSALICYLIC ACID; BLOOD CLOTTING FACTOR 10; DABIGATRAN; RIVAROXABAN; SPHINGOSINE 1 PHOSPHATE; SPHINGOSINE KINASE; THROMBIN; BLOOD CLOTTING FACTOR 10A; LYSOPHOSPHOLIPID; PHOSPHOTRANSFERASE; SPHINGOSINE; SPHINGOSINE 1-PHOSPHATE; SPHINGOSINE KINASE 1;

ACUTE CORONARY SYNDROME; ACUTE HEART INFARCTION; ATHEROSCLEROSIS; BLOOD CLOTTING; BLOOD VESSEL INJURY; CELL MIGRATION; CELL PROLIFERATION; DISEASE COURSE; ENDOTHELIUM CELL; HUMAN; INFLAMMATION; MONOCYTE; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; THROMBOCYTE; THROMBOCYTE ACTIVATION; ANALOGS AND DERIVATIVES; METABOLISM; PATHOLOGY; PHYSIOLOGY; VASCULAR ENDOTHELIUM; VASCULAR SMOOTH MUSCLE; ARTERY THROMBOSIS; EX VIVO STUDY; IN VIVO STUDY; NONHUMAN; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; THROMBOCYTE RICH PLASMA; THROMBOCYTOPENIA;

BLOOD COAGULATION; BLOOD PLATELETS; ENDOTHELIUM, VASCULAR; FACTOR XA; HUMANS; INFLAMMATION; LYSOPHOSPHOLIPIDS; MUSCLE, SMOOTH, VASCULAR; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR); SIGNAL TRANSDUCTION; SPHINGOSINE; THROMBIN;

EID: 84904017360     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000362994     Document Type: Review

References (90)

1. Nurden AT: Platelets, inflammation and tissue regeneration. Thromb Haemost 2011;105 Suppl 1:S13-S33.
2. Levi M, van der Poll T, Schultz M: Infection and inflammation as risk factors for thrombosis and atherosclerosis. Semin Thromb Hemost 2012;38:506-514.
3. Krupiczojc MA, Scotton CJ, Chambers RC: Coagulation signalling following tissue injury: focus on the role of factor Xa. Int J Biochem Cell Biol 2008;40:1228-1237.
4. Owens AP, 3rd, Mackman N: Role of tissue factor in atherothrombosis. Curr Atheroscler Rep 2012;14:394-401.
5. Kalz J, ten Cate H, Spronk HM: Thrombin generation and atherosclerosis. J Thromb Thrombolysis 2014;37:45-55.
6. Borensztajn K, Peppelenbosch MP, Spek CA: Factor Xa: at the crossroads between coagulation and signaling in physiology and disease. Trends Mol Med 2008;14:429-440.
7. Brummel KE, Paradis SG, Butenas S, Mann KG: Thrombin functions during tissue factor-induced blood coagulation. Blood 2002;100:148-152. (Pubitemid 35177440)
8. Rosenkranz AC, Schrör K, Rauch BH: Direct inhibitors of thrombin and factor Xa attenuate clot-induced mitogenesis and inflammatory gene expression in human vascular smooth muscle cells. Thromb Haemost 2011;106:561-562.
9. Schrör K, Bretschneider E, Fischer K, Fischer JW, Pape R, Rauch BH, Rosenkranz AC, Weber AA: Thrombin receptors in vascular smooth muscle cells-function and regulation by vasodilatory prostaglandins. Thromb Haemost 2010;103:884-890.
10. Ma L, Dorling A: The roles of thrombin and protease-activated receptors in inflammation. Semin Immunopathol 2012;34:63-72.
11. Rothmeier AS, Ruf W: Protease-activated receptor 2 signaling in inflammation. Semin Immunopathol 2012;34:133-149.
12. Coughlin SR: Protease-activated receptors in hemostasis, thrombosis and vascular biology. J Thromb Haemost 2005;3:1800-1814. (Pubitemid 41716567)
13. Rauch BH, Bretschneider E, Braun M, Schrör K: Factor Xa releases matrix metalloproteinase-2 (MMP-2) from human vascular smooth muscle cells and stimulates the conversion of pro-MMP-2 to MMP-2: role of MMP-2 in factor Xa-induced DNA synthesis and matrix invasion. Circ Res 2002;90:1122-1127. (Pubitemid 34627912)
14. Rauch BH, Millette E, Kenagy RD, Daum G, Clowes AW: Thrombin-and factor Xa-induced DNA synthesis is mediated by transactivation of fibroblast growth factor receptor-1 in human vascular smooth muscle cells. Circ Res 2004;94:340-345. (Pubitemid 38240725)
15. Borensztajn K, Spek CA: Blood coagulation factor Xa as an emerging drug target. Expert Opin Ther Targets 2011;15:341-349.
16. Shah R: Protease-activated receptors in cardiovascular health and diseases. Am Heart J2009;157:253-262.
17. Maceyka M, Harikumar KB, Milstien S, Spiegel S: Sphingosine-1-phosphate signaling and its role in disease. Trends Cell Biol 2012;22:50-60.
18. Obinata H, Hla T: Sphingosine 1-phosphate in coagulation and inflammation. Semin Immunopathol 2012;34:73-91.
19. Hammad SM, Pierce JS, Soodavar F, Smith KJ, Al Gadban MM, Rembiesa B, Klein RL, Hannun YA, Bielawski J, Bielawska A: Blood sphingolipidomics in healthy humans: impact of sample collection methodology. J Lipid Res 2010;51:3074-3087.
20. Chalfant CE, Spiegel S: Sphingosine 1-phosphate and ceramide 1-phosphate: expanding roles in cell signaling. J Cell Sci 2005;118:4605-4612. (Pubitemid 41646371)
21. Kunkel GT, Maceyka M, Milstien S, Spiegel S: Targeting the sphingosine-1-phosphate axis in cancer, inflammation and beyond. Nat Rev Drug Discov 2013;12:688-702.
22. Ulrych T, Böhm A, Polzin A, Daum G, Nusing RM, Geisslinger G, Hohlfeld T, Schrör K, Rauch BH: Release of sphingosine-1-phosphate from human platelets is dependent on thromboxane formation. J Thromb Haemost 2011;9:790-798.
23. Knapp M, Baranowski M, Czarnowski D, Lisowska A, Zabielski P, Gorski J, Musial W: Plasma sphingosine-1-phosphate concentration is reduced in patients with myocardial infarction. Med Sci Monit 2009;15:CR490-CR493.
24. Sattler KJ, Elbasan S, Keul P, Elter-Schulz M, Bode C, Graler MH, Brocker-Preuss M, Budde T, Erbel R, Heusch G, Levkau B: Sphingosine 1-phosphate levels in plasma and HDL are altered in coronary artery disease. Basic Res Cardiol 2010;105:821-832.
25. Cyster JG, Schwab SR: Sphingosine-1-phosphate and lymphocyte egress from lymphoid organs. Annu Rev Immunol 2012;30:69-94.
26. Green JA, Suzuki K, Cho B, Willison LD, Palmer D, Allen CD, Schmidt TH, Xu Y, Proia RL, Coughlin SR, Cyster JG: The sphingosine 1-phosphate receptor S1P(2) maintains the homeostasis of germinal center B cells and promotes niche confinement. Nat Immunol 2011;12:672-680.
27. Venkataraman K, Lee YM, Michaud J, Thangada S, Ai Y, Bonkovsky HL, Parikh NS, Habrukowich C, Hla T: Vascular endothelium as a contributor of plasma sphingosine 1-phosphate. Circ Res 2008;102:669-676. (Pubitemid 351457860)
28. Olivera A, Allende ML, Proia RL: Shaping the landscape: metabolic regulation of S1P gradients. Biochim Biophys Acta 2013;1831:193-202.
29. Venkataraman K, Thangada S, Michaud J, Oo ML, Ai Y, Lee YM, Wu M, Parikh NS, Khan F, Proia RL, Hla T: Extracellular export of sphingosine kinase-1a contributes to the vascular S1P gradient. Biochem J 2006;397:461-471. (Pubitemid 44187504)
30. Melendez AJ, Carlos-Dias E, Gosink M, Allen JM, Takacs L: Human sphingosine kinase: molecular cloning, functional characterization and tissue distribution. Gene 2000;251:19-26. (Pubitemid 30339413)
31. Liu H, Sugiura M, Nava VE, Edsall LC, Kono K, Poulton S, Milstien S, Kohama T, Spiegel S: Molecular cloning and functional characterization of a novel mammalian sphingosine kinase type 2 isoform. J Biol Chem 2000;275:19513-19520. (Pubitemid 30441543)
32. Mattie M, Brooker G, Spiegel S: Sphingosine-1-phosphate, a putative second messenger, mobilizes calcium from internal stores via an inositol trisphosphate-independent pathway. J Biol Chem 1994;269:3181-3188. (Pubitemid 24237627)
33. Zhang H, Desai NN, Olivera A, Seki T, Brooker G, Spiegel S: Sphingosine-1-phosphate, a novel lipid, involved in cellular proliferation. J Cell Biol 1991;114:155-167. (Pubitemid 21909788)
34. Blaho VA, Hla T: An update on the biology of sphingosine 1-phosphate receptors. J Lipid Res 2014
35. Chun J, Hla T, Lynch KR, Spiegel S, Moolenaar WH: International Union of Basic and Clinical Pharmacology. LXXVIII. Lysophospholipid receptor nomenclature. Pharmacol Rev 2010;62:579-587.
36. Takabe K, Spiegel S: Export of Sphingosine-1-Phosphate and Cancer Progression. J Lipid Res 2014; in press.
37. Zhang L, Orban M, Lorenz M, Barocke V, Braun D, Urtz N, Schulz C, von Bruhl ML, Tirniceriu A, Gaertner F, Proia RL, Graf T, Bolz SS, Montanez E, Prinz M, Muller A, von Baumgarten L, Billich A, Sixt M, Fassler R, von Andrian UH, Junt T, Massberg S: A novel role of sphingosine 1-phosphate receptor S1pr1 in mouse thrombopoiesis. J Exp Med 2012;209:2165-2181.
38. Ratajczak MZ, Suszynska M, Borkowska S, Ratajczak J, Schneider G: The role of sphingosine-1 phosphate and ceramide-1 phosphate in trafficking of normal stem cells and cancer cells. Expert Opin Ther Targets 2014;18:95-107.
39. Rauch BH, Scholz GA, Baumgartel-Allekotte D, Censarek P, Fischer JW, Weber AA, Schrör K: Cholesterol enhances thrombin-induced release of fibroblast growth factor-2 in human vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 2007;27:e20-e25. (Pubitemid 46606700)
40. Kalmes A, Daum G, Clowes AW: EGFR transactivation in the regulation of SMC function. Ann N Y Acad Sci 2001;947:42-55. (Pubitemid 34059902)
41. Rauch BH, Rosenkranz AC, Ermler S, Böhm A, Driessen J, Fischer JW, Sugidachi A, Jakubowski JA, Schrör K: Regulation of functionally active P2Y12 ADP receptors by thrombin in human smooth muscle cells and the presence of P2Y12 in carotid artery lesions. Arterioscler Thromb Vasc Biol 2010;30:2434-2442.
42. Billich A, Urtz N, Reuschel R, Baumruker T: Sphingosine kinase 1 is essential for proteinase-activated receptor-1 signalling in epithelial and endothelial cells. Int J Biochem Cell Biol 2009;41:1547-1555.
43. Niessen F, Schaffner F, Furlan-Freguia C, Pawlinski R, Bhattacharjee G, Chun J, Derian CK, Andrade-Gordon P, Rosen H, Ruf W: Dendritic cell PAR1-S1P3 signalling couples coagulation and inflammation. Nature 2008;452:654-658. (Pubitemid 351483355)
44. Bretschneider E, Wittpoth M, Glusa E, Schrör K: The role of NF kappa B in thrombin-induced mitogenesis of vascular smooth muscle cells. Thromb Haemost 1997:P1414-P1414.
45. Mahajan SG, Fender AC, Meyer-Kirchrath J, Kurt M, Barth M, Sagban TA, Fischer JW, Schrör K, Hohlfeld T, Rauch BH: A novel function of FoxO transcription factors in thrombin-stimulated vascular smooth muscle cell proliferation. Thromb Haemost 2012;108:148-158.
46. Böhm A, Flößer A, Ermler S, Fender AC, Luth A, Kleuser B, Schrör K, Rauch BH: Factor-Xa-induced mitogenesis and migration require sphingosine kinase activity and S1P formation in human vascular smooth muscle cells. Cardiovasc Res 2013;99:505-513.
47. Xiang SY, Dusaban SS, Brown JH: Lysophospholipid receptor activation of RhoA and lipid signaling pathways. Biochim Biophys Acta 2013;1831:213-222.
48. Borissoff JI, Heeneman S, Kilinc E, Kassak P, Van Oerle R, Winckers K, Govers-Riemslag JW, Hamulyak K, Hackeng TM, Daemen MJ, ten Cate H, Spronk HM: Early atherosclerosis exhibits an enhanced procoagulant state. Circulation 2010;122:821-830.
49. Zhang L, Urtz N, Gaertner F, Legate KR, Petzold T, Lorenz M, Mazharian A, Watson SP, Massberg S: Sphingosine kinase 2 (Sphk2) regulates platelet biogenesis by providing intracellular sphingosine 1-phosphate (S1P). Blood 2013;122:791-802.
50. Tani M, Sano T, Ito M, Igarashi Y: Mechanisms of sphingosine and sphingosine 1-phosphate generation in human platelets. J Lipid Res 2005;46:2458-2467. (Pubitemid 41532534)
51. Tani M, Ito M, Igarashi Y: Ceramide/sphingosine/sphingosine 1-phosphate metabolism on the cell surface and in the extracellular space. Cell Signal 2007;19:229-237. (Pubitemid 44969975)
52. Yatomi Y, Igarashi Y, Yang L, Hisano N, Qi R, Asazuma N, Satoh K, Ozaki Y, Kume S: Sphingosine 1-phosphate, a bioactive sphingolipid abundantly stored in platelets, is a normal constituent of human plasma and serum. J Biochem 1997;121:969-973. (Pubitemid 27236918)
53. Ono Y, Kurano M, Ohkawa R, Yokota H, Igarashi K, Aoki J, Tozuka M, Yatomi Y: Sphingosine 1-phosphate release from platelets during clot formation: close correlation between platelet count and serum sphingosine 1-phosphate concentration. Lipids Health Dis 2013;12:20.
54. Polzin A, Rassaf T, Böhm A, Luth A, Kleuser B, Zeus T, Kelm M, Kroemer HK, Schrör K, Rauch BH: Aspirin inhibits release of platelet-derived sphingosine-1-phosphate in acute myocardial infarction. Int J Cardiol 2013;170:e23-e24.
55. Yatomi Y, Ohmori T, Rile G, Kazama F, Okamoto H, Sano T, Satoh K, Kume S, Tigyi G, Igarashi Y, Ozaki Y: Sphingosine 1-phosphate as a major bioactive lysophospholipid that is released from platelets and interacts with endothelial cells. Blood 2000;96:3431-3438.
56. English D, Welch Z, Kovala AT, Harvey K, Volpert OV, Brindley DN, Garcia JG: Sphingosine 1-phosphate released from platelets during clotting accounts for the potent endothelial cell chemotactic activity of blood serum and provides a novel link between hemostasis and angiogenesis. Faseb J 2000;14:2255-2265.
57. Kobayashi N, Kobayashi N, Yamaguchi A, Nishi T: Characterization of the ATP-dependent sphingosine 1-phosphate transporter in rat erythrocytes. J Biol Chem 2009;284:21192-21200.
58. Mitra P, Oskeritzian CA, Payne SG, Beaven MA, Milstien S, Spiegel S: Role of ABCC1 in export of sphingosine-1-phosphate from mast cells. Proc Natl Acad Sci U S A 2006;103:16394-16399. (Pubitemid 44715207)
59. Jedlitschky G, Greinacher A, Kroemer HK: Transporters in human platelets: physiologic function and impact for pharmacotherapy. Blood 2012;119:3394-3402.
60. Jedlitschky G, Tirschmann K, Lubenow LE, Nieuwenhuis HK, Akkerman JW, Greinacher A, Kroemer HK: The nucleotide transporter MRP4 (ABCC4) is highly expressed in human platelets and present in dense granules, indicating a role in mediator storage. Blood 2004;104:3603-3610. (Pubitemid 39564434)
61. Knapp M, Lisowska A, Knapp P, Baranowski M: Dose-dependent effect of aspirin on the level of sphingolipids in human blood. Adv Med Sci 2013;58:274-281.
62. Knapp M, Lisowska A, Zabielski P, Musial W, Baranowski M: Sustained decrease in plasma sphingosine-1-phosphate concentration and its accumulation in blood cells in acute myocardial infarction. Prostaglandins Other Lipid Mediat 2013;106:53-61.
63. Yatomi Y, Ruan F, Hakomori S, Igarashi Y: Sphingosine-1-phosphate: a platelet-activating sphingolipid released from agonist-stimulated human platelets. Blood 1995;86:193-202.
64. Nugent D, Xu Y: Sphingosine-1-phosphate: characterization of its inhibition of platelet aggregation. Platelets 2000;11:226-232. (Pubitemid 30479683)
65. Hisano Y, Kobayashi N, Yamaguchi A, Nishi T: Mouse SPNS2 functions as a sphingosine-1-phosphate transporter in vascular endothelial cells. PLoS One 2012;7:e38941.
66. Fukuhara S, Simmons S, Kawamura S, Inoue A, Orba Y, Tokudome T, Sunden Y, Arai Y, Moriwaki K, Ishida J, Uemura A, Kiyonari H, Abe T, Fukamizu A, Hirashima M, Sawa H, Aoki J, Ishii M, Mochizuki N: The sphingosine-1-phosphate transporter Spns2 expressed on endothelial cells regulates lymphocyte trafficking in mice. J Clin Invest 2012;122:1416-1426.
67. Mendoza A, Breart B, Ramos-Perez WD, Pitt LA, Gobert M, Sunkara M, Lafaille JJ, Morris AJ, Schwab SR: The transporter Spns2 is required for secretion of lymph but not plasma sphingosine-1-phosphate. Cell Rep 2012;2:1104-1110.
68. Zhang W, An J, Jawadi H, Siow DL, Lee JF, Zhao J, Gartung A, Maddipati KR, Honn KV, Wattenberg BW, Lee MJ: Sphingosine-1-phosphate receptor-2 mediated NFkappaB activation contributes to tumor necrosis factor-alpha induced VCAM-1 and ICAM-1 expression in endothelial cells. Prostaglandins Other Lipid Mediat 2013;106:62-71.
69. Zhang G, Yang L, Kim GS, Ryan K, Lu S, O'Donnell RK, Spokes K, Shapiro N, Aird WC, Kluk MJ, Yano K, Sanchez T: Critical role of sphingosine-1-phosphate receptor 2 (S1PR2) in acute vascular inflammation. Blood 2013;122:443-455.
70. McVerry BJ, Garcia JG: Endothelial cell barrier regulation by sphingosine 1-phosphate. J Cell Biochem 2004;92:1075-1085. (Pubitemid 44264219)
71. Siess W: Athero-and thrombogenic actions of lysophosphatidic acid and sphingosine-1-phosphate. Biochim Biophys Acta 2002;1582:204-215. (Pubitemid 34634131)
72. Feistritzer C, Riewald M: Endothelial barrier protection by activated protein C through PAR1-dependent sphingosine 1-phosphate receptor-1 crossactivation. Blood 2005;105:3178-3184.
73. Popovic M, Smiljanic K, Dobutovic B, Syrovets T, Simmet T, Isenovic ER: Thrombin and vascular inflammation. Mol Cell Biochem 2012;359:301-313.
74. Garcia JG, Verin AD, Schaphorst KL: Regulation of thrombin-mediated endothelial cell contraction and permeability. Semin Thromb Hemost 1996;22:309-315. (Pubitemid 26414408)
75. Tauseef M, Kini V, Knezevic N, Brannan M, Ramchandaran R, Fyrst H, Saba J, Vogel SM, Malik AB, Mehta D: Activation of sphingosine kinase-1 reverses the increase in lung vascular permeability through sphingosine-1-phosphate receptor signaling in endothelial cells. Circ Res 2008;103:1164-1172.
76. Niessen F, Furlan-Freguia C, Fernandez JA, Mosnier LO, Castellino FJ, Weiler H, Rosen H, Griffin JH, Ruf W: Endogenous EPCR/aPC-PAR1 signaling prevents inflammation-induced vascular leakage and lethality. Blood 2009;113:2859-2866.
77. Takeya H, Gabazza EC, Aoki S, Ueno H, Suzuki K: Synergistic effect of sphingosine 1-phosphate on thrombin-induced tissue factor expression in endothelial cells. Blood 2003;102:1693-1700. (Pubitemid 37022562)
78. Chiba K, Adachi K: Discovery of fingolimod, the sphingosine 1-phosphate receptor modulator and its application for the therapy of multiple sclerosis. Future Med Chem 2012;4:771-781.
79. Campos F, Qin T, Castillo J, Seo JH, Arai K, Lo EH, Waeber C: Fingolimod reduces hemorrhagic transformation associated with delayed tissue plasminogen activator treatment in a mouse thromboembolic model. Stroke 2013;44:505-511.
80. Ghattas A, Griffiths HR, Devitt A, Lip GY, Shantsila E: Monocytes in coronary artery disease and atherosclerosis: where are we now? J Am Coll Cardiol 2013;62:1541-1551.
81. Domsalla A, Melzig MF: Enhancement of protease-induced IL-6 release in monocytic U-937 cells by phorbol-12-myristate-13-acetate. Inflamm Res 2012;61:1125-1129.
82. Gadepalli R, Kotla S, Heckle MR, Verma SK, Singh NK, Rao GN: Novel role for p21-activated kinase 2 in thrombin-induced monocyte migration. J Biol Chem 2013;288:30815-30831.
83. Shpacovitch V, Feld M, Hollenberg MD, Luger TA, Steinhoff M: Role of protease-activated receptors in inflammatory responses, innate and adaptive immunity. J Leukoc Biol 2008;83:1309-1322. (Pubitemid 351960309)
84. Keul P, Tolle M, Lucke S, von Wnuck Lipinski K, Heusch G, Schuchardt M, van der Giet M, Levkau B: The sphingosine-1-phosphate analogue FTY720 reduces atherosclerosis in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 2007;27:607-613.
85. Böhm A, Sostmann B, Rauch BH: The bioactive lipid sphingosine-1-phosphate enhances thrombin-induced migration of human monocytes via transcriptional regulation of the protease-activated receptor-4. Naunyn Schmiedebergs Arch Pharmacol 2013;386:S11-S12.
86. Conkling PR, Patton KL, Hannun YA, Greenberg CS, Weinberg JB: Sphingosine inhibits monocyte tissue factor-initiated coagulation by altering factor VII binding. J Biol Chem 1989;264:18440-18444. (Pubitemid 19277586)
87. Gude DR, Alvarez SE, Paugh SW, Mitra P, Yu J, Griffiths R, Barbour SE, Milstien S, Spiegel S: Apoptosis induces expression of sphingosine kinase 1 to release sphingosine-1-phosphate as a "come-and-get-me" signal. Faseb J 2008;22:2629-2638.
88. Young A, Chapman O, Connor C, Poole C, Rose P, Kakkar AK: Thrombosis and cancer. Nat Rev Clin Oncol 2012;9:437-449.
89. Franchini M, Mannucci PM: Thrombin and cancer: from molecular basis to therapeutic implications. Semin Thromb Hemost 2012;38:95-101.
90. Kraft P, Gob E, Schuhmann MK, Gobel K, Deppermann C, Thielmann I, Herrmann AM, Lorenz K, Brede M, Stoll G, Meuth SG, Nieswandt B, Pfeilschifter W, Kleinschnitz C: FTY720 ameliorates acute ischemic stroke in mice by reducing thrombo-inflammation but not by direct neuroprotection. Stroke 2013;44:3202-3210.